Cryotherapy to Prevent Eyelash Loss from Chemo
Part of Cancer, Skin clinical trials.
This trial tests if cooling the eyelids during chemotherapy can prevent eyelash loss in women with newly diagnosed breast cancer. It is for those who have not yet started treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been newly diagnosed with breast cancer (any stage).
- You are scheduled to receive chemotherapy with a type called anthracycline or taxane as your first treatment.
- You have not had any cancer treatment before (like chemotherapy, hormone therapy, or immunotherapy).
- You do not already have hair loss on your scalp.
- You have not had radiation therapy to the brain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether cooling the scalp during chemotherapy can help reduce chemotherapy-related hair loss. It focuses on people with curly or kinky hair who are having certain cancer treatments, and it checks safety and how much hair loss happens.
This study tests if a cooling cap can help reduce hair loss during chemotherapy for breast cancer. Hair loss can be distressing, and this trial aims to see if the cap helps you keep more hair while still getting the treatment you need.
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
This study looks at whether “cold cap” scalp cooling can help prevent or reduce hair loss in children getting chemotherapy. It’s aimed at kids treated with certain chemotherapy medicines and who may be at risk for losing their hair.
This study tests whether a cooling cap can prevent hair loss in women receiving specific antibody-drug conjugates (trastuzumab-deruxtecan, sacituzumab-govitecan, or datopotamab-deruxtecan) for advanced solid tumors. If it works, you may keep more of your hair during treatment.
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.